Johnson & Johnson Hip Implant Recall
Startling failure rates led Johnson & Johnson to recall defective hip devices implanted in more than 93,000 people around the world. The recall applies to the ASR XL Acetubular System and the ASR Hip Resurfacing System. DePuy, a division of Johnson & Johnson, says “more people than expected” experienced pain and other symptoms, requiring 1 out of every 8 patients to undergo additional surgery within five years of receiving the implant. The company recommends that patients see their implant surgeons immediately for a full evaluation, and plans to cover the cost of “reasonable” monitoring and treatment for services associated with the recall.
The recall comes on the heels of an FDA warning letter notifying DePuy last month that it was illegally marketing two similar replacement-joint products without approval. Parent company Johnson & Johnson is also under heavy scrutiny from Congress and federal prosecutors after eight non-prescription medication recalls in the last year.